Rather paradoxically, as shown in Figure 4, the IDH1 wild-type gene actually confers worse prognosis in glial cell tumours, being associated with WHO grade 3/4 glioblastoma, whereas, IDH1 mutation confers a better long-term prognosis. This evidence concerns the gene IDH1 and glioblastoma.